SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Anti-VEGF treatment maintains acuity over 10 years

    Posted on October 23, 2020 by Dan Roberts
  • October 23, 2020

    Anti-VEGF treatment maintains acuity over 10 years

    Patients receiving continuous injections of anti-VEGF drugs for treatment of wet age related macular degeneration (wAMD) can take comfort in knowing that they are keeping their initial visual acuity long term. As reported in the September 29 issue of  Ophthalmology Retina, the LATAR study found that 293 eyes not only maintained their original visual acuity, […]

      Also posted in
    • Latest News
    • Therapies, Treatments, and Procedures
  • Levodopa may improve vision in patients with Wet AMD

    Posted on September 15, 2020September 15, 2020 by Dan Roberts
  • September 15, 2020

    Levodopa may improve vision in patients with Wet AMD

    Investigators have determined that treating patients with the early wet form of age-related macular degeneration (AMD) with levodopa, stabilized and improved their vision. Levodopa is a safe and readily available drug commonly used to treat Parkinson’s disease, The drug reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the […]

      Also posted in
    • Latest News
    • Research and Developments
  • Innovative Glaucoma Platform Launched

    Posted on September 9, 2020January 3, 2021 by Dan Roberts
  • September 9, 2020

    Innovative Glaucoma Platform Launched

    It has been said, “Just because you have the measles doesn’t mean you can’t catch chicken pox”. Many people affected by macular degeneration and other diseases of the eye have learned that glaucoma is often a secondary condition with which they must also deal. “Today, there are more than an estimated 3.2 million Americans that […]

      Also posted in
    • Daily Living
    • Latest News
  • Zimura® Shows Significant Suppression of Geographic Atrophy

    Posted on September 8, 2020 by Dan Roberts
  • September 8, 2020

    Zimura® Shows Significant Suppression of Geographic Atrophy

    IVERIC bio, Inc. has announced positive Phase 3 results from its GATHER1 clinical trial with Zimura® (avacincaptad pegol). As published in the September issue of Ophthalmology®, Zimura® met its pre-specified primary efficacy endpoint at 12 months and reached statistical significance in GATHER1, an international, multicenter, randomized, double masked, sham controlled clinical trial.  Zimura® inhibits complement […]

      Also posted in
    • Research and Developments
  • AAO Cautions About Red Light Therapy

    Posted on September 7, 2020September 7, 2020 by Dan Roberts
  • September 7, 2020

    AAO Cautions About Red Light Therapy

    An article published here in August 2020 announced that positive results were obtained from a study of photobiomodulation (PBM)–also known as “red light therapy”– as a treatment for eye diseases such as AMD, retinopathy of prematurity, and diabetic macular edema. The American Academy of Ophthalmology has simultaneously posted cautionary remarks about recent PBM research. In […]

      Also posted in
    • Research and Developments
  • “He Don’t See So Good”

    Posted on September 4, 2020September 6, 2020 by Dan Roberts
  • September 4, 2020

    “He Don’t See So Good”

    Charles Barnhart’s Story from “Inspirational Stories of the Visually Challenged (plus Resources)“by Margaret Barnhart Do you suppose I might hold a record for ways to meet a husband, as in lying naked on his massage table covered with sheets exactly the way he told me? This was my first ever massage. I was nervous. The […]

      Also posted in
    • Essay
  • Light Therapy Showing Success As Retinal Treatment

    Posted on August 17, 2020August 17, 2020 by Dan Roberts
  • August 17, 2020

    Light Therapy Showing Success As Retinal Treatment

    According to an article in the August 6, 2020 edition of Ophthalmology Times, a procedure called photobiomodulation (PBM) has had recent success in treating eye diseases such as AMD, retinopathy of prematurity, and diabetic macular edema. PBM, or low-level light therapy, is the application of monochromatic light to a part of the body with the […]

      Also posted in
    • Latest News
    • Research and Developments
    • Therapies, Treatments, and Procedures
  • “Lookout” app now available for all Android devices

    Posted on August 14, 2020April 2, 2022 by Dan Roberts
  • August 14, 2020

    “Lookout” app now available for all Android devices

    We reported here in March 2019 that Google had created a new Android app called Lookout to help the visually impaired. Similar to Microsoft’s Seeing AI for Apple devices, the application uses artificial intelligence (AI) combined with Talk Back to identify objects, read text, scan barcodes, and identify currencies. At that time, Lookout was available only for Google’s […]

      Also posted in
    • Daily Living
    • Latest News
  • Gene therapy treatment for wet AMD shows positive results

    Posted on August 11, 2020December 11, 2020 by Dan Roberts
  • August 11, 2020

    Gene therapy treatment for wet AMD shows positive results

    (Updated 12/11/2020) REGENXBIO, Inc. has reported positive one year data from patients in Cohorts 4 and 5 of the Phase I/IIa trial of RGX-314 for the treatment of wet age-related macular degeneration (wet AMD). As reported here in June 2017, RGX-314 is being developed as a one-time sub-retinal injection for wet AMD. It would be […]

      Also posted in
    • Latest News
    • Research and Developments
  • AMD associated with greater COVID mortality

    Posted on August 3, 2020August 3, 2020 by Dan Roberts
  • August 3, 2020

    AMD associated with greater COVID mortality

    The human’s natural immune system (called complement) has been found to be associated with the severity of COVID disease in people with age-related macular degeneration (AMD), according to a new study published in Nature Medicine. A hyperactive complement system is known to be directly related to development of AMD. In a retrospective observational study of […]

      Also posted in
    • Latest News
    • Research and Developments
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 52
  • Next Page »
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.